We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMIF icon
6751
iShares Emerging Markets Infrastructure ETF
EMIF
$13.2M
$45.1K ﹤0.01%
2,107
-280
-12% -$6.22K
KOCT icon
6752
Innovator US Small Cap Power Buffer ETF October
KOCT
$136M
$45K ﹤0.01%
1,575
+1,496
+1,894% +$42.2K
SURG icon
6753
SurgePays
SURG
$8.16M
$45K ﹤0.01%
14,113
+8,274
+142% +$31.3K
HYB
6754
DELISTED
New America High Income Fund, Inc.
HYB
$44.9K ﹤0.01%
6,126
-6,680
-52% -$48.1K
IAPR icon
6755
Innovator International Developed Power Buffer ETF April
IAPR
$201M
$44.9K ﹤0.01%
1,660
+1,562
+1,594% +$42.2K
EVG
6756
Eaton Vance Short Duration Diversified Income Fund
EVG
$142M
$44.9K ﹤0.01%
4,154
-4,673
-53% -$50K
DSGN icon
6757
Design Therapeutics
DSGN
$862M
$44.8K ﹤0.01%
13,360
-19,673
-60% -$76.7K
BSEP icon
6758
Innovator US Equity Buffer ETF September
BSEP
$216M
$44.7K ﹤0.01%
1,099
+1,095
+27,375% +$43.3K
AVTX icon
6759
Avalo Therapeutics
AVTX
$989M
$44.7K ﹤0.01%
3,583
-4,130
-54% -$53.6K
OPI
6760
DELISTED
Office Properties Income Trust
OPI
$44.7K ﹤0.01%
21,890
-33,362
-60% -$72.5K
WAY
6761
Waystar Holding Corp
WAY
$4.48B
$44.7K ﹤0.01%
+2,077
New +$45K
SFEB
6762
FT Vest US Small Cap Moderate Buffer ETF February
SFEB
$130M
$44.5K ﹤0.01%
+2,213
New +$44.2K
VLRS
6763
Controladora Vuela Compania de Aviacion
VLRS
$925M
$44.4K ﹤0.01%
6,985
-30,531
-81% -$235K
FENC icon
6764
Fennec Pharmaceuticals
FENC
$377M
$44.4K ﹤0.01%
7,268
-22,350
-75% -$186K
ONFO icon
6765
Onfolio Holdings
ONFO
$422K
$44.3K ﹤0.01%
38,223
+19,538
+105% +$15.4K
FHTX icon
6766
Foghorn Therapeutics
FHTX
$327M
$44.2K ﹤0.01%
7,691
-12,683
-62% -$75.5K
GCOR icon
6767
Goldman Sachs Access US Aggregate Bond ETF
GCOR
$797M
$44.2K ﹤0.01%
1,083
+239
+28% +$9.69K
AVAH icon
6768
Aveanna Healthcare
AVAH
$2.03B
$44.1K ﹤0.01%
15,992
-35,053
-69% -$87.4K
USDU icon
6769
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$458M
$44.1K ﹤0.01%
1,629
+724
+80% +$19.3K
NCNC
6770
DELISTED
noco-noco Inc. Ordinary Share
NCNC
$44.1K ﹤0.01%
249,143
+128,849
+107% +$27.2K
RAFE icon
6771
PIMCO RAFI ESG US ETF
RAFE
$168M
$44.1K ﹤0.01%
+1,251
New +$43.1K
TRAW icon
6772
Traws Pharma
TRAW
$8.21M
$44.1K ﹤0.01%
3,943
+3,932
+35,745% +$63.4K
NEXR
6773
Nexera Technologies Ltd
NEXR
$1.41M
$44.1K ﹤0.01%
+4
New +$44.5K
DDL
6774
Dingdong
DDL
$490M
$44K ﹤0.01%
22,128
+12,707
+135% +$21.3K
DAPR icon
6775
FT Vest US Equity Deep Buffer ETF April
DAPR
$312M
$44K ﹤0.01%
1,246
-157
-11% -$5.39K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.